Clinical and biological markers for predicting acute respiratory distress syndrome in sepsis patients: a systematic review and meta-analysis
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240537Keywords:
ARDS, Biological markers, Clinical markers, SepsisAbstract
Sepsis is a serious condition that occurs when a person's immune system responds excessively to an infection, causing an inflammatory reaction that damages the body's organs. One of the complications that can occur in sepsis patients is acute respiratory distress syndrome (ARDS). Sepsis and ARDS are conditions with high mortality rates, so it is important to prevent them. This study aims to determine clinical and biological markers that can be used as a reference in predicting ARDS in sepsis patients, so that prevention efforts can be carried out quickly and precisely. We performed a search in two databases (PubMed and Cochrane) for articles published between January 1, 2013 and September 30, 2023 that reported markers or predictors of ARDS in sepsis patients. Eleven studies out of the 360 articles identified, met the inclusion criteria for this review. APACHE II score (MD 0.36; 95% CI=0.15-0.56), sequential organ failure assessment score (SOFA) score (Mean difference (MD)=0.50; 95% CI=0.04-0.97), CRP (MD=0.75; 95% CI=0.46-1.04), SP-D (MD=0.70; 95% CI=0.51-0.90), and serum receptor for advanced glycation end-products (sRAGE) (MD=0.72; 95% CI=0.59-0.84) have a significant influence on the incidence of ARDS in sepsis patients. Overall, the findings of a meta-analysis that included 11 studies involving 6,623 patients showed that the APACHE II score, SOFA score, CRP, SP-D, and sRAGE showed statistically significant values.
References
Englert JA, Bobba C, Baron RM. Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome. JCI Insight. 2019;4(2):e124061.
Badraoui R, Alrashedi MM, El-May MV, Bardakci F. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19. J Biomol Struct Dyn. 2021;39(17):6842-51.
Toner P, McAuley DF, Shyamsundar M. Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome. Crit Care. 2015;19:374.
Mehta Y, Dixit SB, Zirpe KG, Ansari AS. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations. Indian J Crit Care Med. 2020;24(6):429-34.
Shukla U, Chavali S, Mukta P, Mapari A, Vyas A. Initial experience of critically ill patients with COVID-19 in western India: A case series. Indian J Crit Care Med. 2020;24(7):509-13.
Sheu CC, Gong MN, Zhai R, Ednan KB, Feng C, Taylor BT et al. The influence of infection sites on development and mortality of ARDS. Intensive Care Med. 2010;36(6):963-70.
Calfee CS, Janz DR, Bernard GR, Addison KM, Kirsten NK, Michael AM et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015;147(6):1539-48.
García-Laorden MI, Lorente JA, Flores C, Slutsky AS, Villar J. Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann Transl Med. 2017;5(14):283.
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-33.
Adams CE, McAuley DF. Acute Respiratory Distress Syndrome. Encyclopedia Respiratory Med. 2022;267-78.
Geyer-Roberts E, Lacatusu DA, Kester J, Foster-Moumoutjis G, Sidiqi M. Preventative Management of Sepsis-Induced Acute Respiratory Distress Syndrome in the Geriatric Population. Cureus. 2023;15(2):e34680.
Gong MN, Thompson BT. Acute respiratory distress syndrome: shifting the emphasis from treatment to prevention. Curr Opin Crit Care. 2016;22(1):21-37.
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-11.
Van der Zee P, Rietdijk W, Somhorst P, Endeman H, Gommers D. A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality. Crit Care. 2020;24(1):243.
Mayow AH, Ahmad F, Afzal MS. A systematic review and meta-analysis of independent predictors for acute respiratory distress syndrome in patients presenting with sepsis. Cureus. 2023;15(4):e37055.
Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld AB. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2014;42(3):691-700.
Li S, Zhao D, Cui J, Wang L, Ma X, Li Y. Prevalence, potential risk factors and mortality rates of acute respiratory distress syndrome in Chinese patients with sepsis. J Int Med Res. 2020;48(2).
Iriyama H, Abe T, Kushimoto S, et al. Risk modifiers of acute respiratory distress syndrome in patients with non-pulmonary sepsis: a retrospective analysis of the FORECAST study. J Intensive Care. 2020;8:7.
Shi Y, Wang L, Yu S, Ma X, Li X. Risk factors for acute respiratory distress syndrome in sepsis patients: a retrospective study from a tertiary hospital in China. BMC Pulm Med. 2022;22(1):238.
Ware LB, Koyama T, Zhao Z, et al. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care. 2013;17(5).
Nam H, Jang SH, Hwang YI, Kim JH, Park JY, Park S. Nonpulmonary risk factors of acute respiratory distress syndrome in patients with septic bacteraemia. Korean J Intern Med. 2019;34(1):116-24.
Yang P, Iffrig E, Harris F, Holder AL, Martin GS, Esper AM. Serial Measurements of Protein Biomarkers in Sepsis-Induced Acute Respiratory Distress Syndrome. Crit Care Explor. 2022;4(10):e0780.
Mikkelsen ME, Shah CV, Meyer NJ, David FG, Sarah L, Andrea NM et al. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock. 2013;40(5):375-81.
Jones TK, Feng R, Kerchberger VE, John PR, Brian JA, Michael GSS et al. Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020;201(1):47-56.
Seethala RR, Hou PC, Aisiku IP, Gyorgy F, Pauline KP, Mark EM et al. Early risk factors and the role of fluid administration in developing acute respiratory distress syndrome in septic patients. Ann Intensive Care. 2017;7(1):11.
Villar J, Herrán-Monge R, González-Higueras E, Prieto-González M, Ambrós A, Rodríguez-Pérez A et al. Clinical and biological markers for predicting ARDS and outcome in septic patients. Sci Rep. 2021;11(1).
Reilly JP, Wang F, Jones TK, Jessica AP, Brian JA, Michael GSS et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis. Intensive Care Med. 2018;44(11):1849-58.
Tian Y, Yao Y, Zhou J, Xin D, Hui C, Kaixia C et al. Dynamic APACHE II Score to Predict the Outcome of Intensive Care Unit Patients. Front Med (Lausanne). 2022;8:744907.
Hu X, Zhang J, Wang P, Dai X. Practice and effect evaluation of early restrictive fluid resuscitation strategy in the nursing care of patients with sepsis in the emergency department: a retrospective cohort study. JBI Evid Implement. 2023;21(3):269-76.
Yang Q, Zhang X, Luo L, Shen J. Clinical application of serum NLRP3 on the diagnosis and prognosis of sepsis patients complicated with acute respiratory distress syndrome. Front Immunol. 2023;14.
Villar J, Pérez-Méndez L, Blanco J, José MA, Lluís B, Javier B et al. A universal definition of ARDS: the PaO2/FiO2 ratio under a standard ventilatory setting--a prospective, multicenter validation study. Intensive Care Med. 2013;39(4):583-92.
Chen W, Janz DR, Shaver CM, Bernard GR, Bastarache JA, Ware LB. Clinical Characteristics and Outcomes Are Similar in ARDS Diagnosed by Oxygen Saturation/Fio2 Ratio Compared with Pao2/Fio2 Ratio. Chest. 2015;148(6):1477-83.
Bajwa EK, Khan UA, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest. 2009;136(2):471-80.
Zhang Z, Ni H. C-reactive protein as a predictor of mortality in critically ill patients: a meta-analysis and systematic review. Anaesth Intensive Care. 2011;39(5):854-61.
Elmore A, Almuntashiri A, Wang X, Almuntashiri S, Zhang D. Circulating Surfactant Protein D: A Biomarker for Acute Lung Injury? Biomedicines. 2023;11(9):2517.
Yang P, Iffrig E, Harris F, Holder AL, Martin GS, Esper AM. Serial Measurements of Protein Biomarkers in Sepsis-Induced Acute Respiratory Distress Syndrome. Crit Care Explor. 2022;4(10):e0780.
Zhang C, Yin D, Zhu X, Wenshuo Z, Zhihua X, Liuping W et al. Predictive value of ELWI combined with sRAGE/esRAGE levels in the prognosis of critically ill patients with acute respiratory distress syndrome. Sci Rep. 2023;13(1).
Jabaudon M, Pereira B, Laroche E, Laurence R, Raiko B, Jules A et al. Changes in Plasma Soluble Receptor for Advanced Glycation End-Products Are Associated with Survival in Patients with Acute Respiratory Distress Syndrome. J Clin Med. 2021;10(10):2076.
